Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Holman RR, Bethel MA, Mentz, RJ, et al
NEJM 2017. September 14, 2017
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
PCSK9 Inhibition and Type 2 Diabetes
Lotta LA, Griffin SJ
Lancet Diabetes Endocrinol. Pub. online September 15, 2017
Leggi
Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Patients With and Without Diabetes and the Effect of Evolocumab on Glycaemia and Risk of New-Onset Diabetes: A Prespecified Analysis of the FOURIER Randomised Controlled Trial
Sabatine MS, Leiter LA, Wiviott SD, et al.
Lancet Diabetes Endocrinol. Pub. online September 15, 2017
Leggi
Impact of Stroke Risk Factors on Ethnic Stroke Disparities Among Midlife Mexican Americans and Non-Hispanic Whites
Pate RCl, Sánchez BN, Morgenstern LB, et al.
Stroke 2017. Pub online September 21, 2017
Leggi
Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
Grodzinsky A, Kosiborod M, Tang F, et al.
Circ Cardiovasc Qual Outcomes. Pub. online September 13, 2017.
Leggi
Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study
Kim Y-G, Yoon D, Park S, et al.
Circ Heart Fail. Pub. online September 12, 2017
Leggi
Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in PatientsWith Type 2 Diabetes Mellitus
Striepe K, Jumar A, Ott C, et al.
Circulation 2017;136(12):1167-9
Leggi
Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes (CONCEPTT): A Multicentre International Randomised Controlled Trial
Feig DS, Donovan LE, Corcoy R, et al. on behalf of the show CONCEPTT Collaborative Group
The Lancet. Pub.online15 September 2017
Leggi
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT-1): 24 Week Results From a Multicentre, Double-Blind, Phase 3, Randomised Controlled Trial
Dandona P, Mathieu C, Phillip M
The Lancet Diabetes & Endocrinology. Pub. online 14 September 2017
Leggi
SGLT2 Inhibitors in Type 1 Diabetes: Knocked Down, But Up Again?
Petrie JR
The Lancet Diabetes & Endocrinology. Pub. online 14 September 2017
Leggi